WASHINGTON — CHPA president and CEO Scott Melville released the following statement in response to Senator Durbin’s and Senator Braun’s Introduction of the Dietary Supplement Listing Act of 2022:
“CHPA appreciates the work of Senators Durbin and Braun and their focus on updating the 28-year-old Dietary Supplement Health and Education Act (DSHEA) of 1994. It is fitting that attention is being placed on DSHEA following the passing of former Senator Orrin Hatch, the author of DSHEA, a testament to his legacy.
“Mandatory Product Listing is an important component of modernizing DSHEA, but more needs to be done to enhance quality, ensure safety, and provide the transparency and predictability needed to promote innovation in the dietary supplement industry. We look forward to continuing to work with the bill sponsors on our shared commitment to provide greater oversight of products that 77 percent of Americans have used over the past calendar year.
“Now, more than ever, consumers are depending on dietary supplements to address nutritional gaps and promote their overall wellness. The industry has grown from $4 billion in 1994 – when the regulatory framework that oversees supplements was first enacted – to more than $50 billion today. However, regulation has not kept pace with changes in the marketplace. The time is ripe for a more comprehensive approach to modernizing DSHEA and CHPA remains committed to working with Congress to share ideas and proposals that will further promote consumer safety and enhance public health.”